摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N2-乙酰基-DL-天冬氨酰胺 | 16473-76-0

中文名称
N2-乙酰基-DL-天冬氨酰胺
中文别名
N2-乙酰基-DL-天冬酰胺
英文名称
N-acetylasaparagine
英文别名
N2-acetyl-asparagine;N2-Acetyl-asparagin;N-acetyl-asparagine;N-Acetyl-d,l-asparagin;2-Acetamido-4-amino-4-oxobutanoic acid
N2-乙酰基-DL-天冬氨酰胺化学式
CAS
16473-76-0
化学式
C6H10N2O4
mdl
MFCD00066022
分子量
174.156
InChiKey
HXFOXFJUNFFYMO-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -1.8
  • 重原子数:
    12
  • 可旋转键数:
    4
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    110
  • 氢给体数:
    3
  • 氢受体数:
    4

安全信息

  • 海关编码:
    2924199090

SDS

SDS:7460114f0b5bd90038abc9a75668416d
查看

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Studies on Hepatic Agents. I. Synthesis of Aminoacyl (and Hydroxyacyl) Aminoacetonitriles
    作者:SEIGO SUZUE、TUTOMU IRIKURA
    DOI:10.1248/cpb.16.1417
    日期:——
    For the purpose of elucidating the structural relationship between lathyrism and inhibition of necrosis induced by CCl4 in the liver of the rat, many compounds related to aminoacetonitrile were synthesized. N-Aminoacylaminoacetonitriles (VIII, XIV) were synthesized from phthaloylaminoacylaminoacetonitriles. VIII were converted to 2-hydroxyimino-5-oxopiperazine derivatives (XV) and 5-oxo-2-thio-piperazines (XX). Preparations of N-(N-acylaminoacyl) aminoacetonitriles were also described. Further, N-α-hydroxyacylaminoacetonitriles were prepared from chloralides of α-hydroxyacids with aminoacetonitrile. In addition, XV (R=H) was converted to 2-acetamino-5-acetoxypyrazine by treatment with acetic anhydride.
    为了阐明贻贝症与四氯化碳诱导的大鼠肝脏坏死抑制之间的结构关系,合成了许多与氨基乙腈相关的化合物。N-氨基酰氨基乙腈(VIII,XIV)是从邻苯二甲酰氨基酰氨基乙腈合成的。VIII被转化为2-羟基亚胺-5-氧杂哌嗪衍生物(XV)和5-氧-2-硫杂哌嗪(XX)。还描述了N-(N-酰氨基酰)氨基乙腈的制备。此外,N-α-羟基酰氨基乙腈是由α-羟基酸的氯化物与氨基乙腈反应制备的。此外,通过用醋酸无水物处理,XV(R=H)被转化为2-乙酰氨基-5-乙酰氧基吡唑。
  • Substituted Phenylpiperazinyl Aralkylalcohol Derivatives, Pharmaceutical Compositions Containing Such Derivatives and Uses Thereof
    申请人:Li Jianqi
    公开号:US20110294822A1
    公开(公告)日:2011-12-01
    The invention relates to a substituted phenylpiperazine aryl alkanol derivative represented by the following general formula and its salt and hydrate, wherein C 1 and C 2 represent chiral carbon atoms, and the compound is one of the six isomers: (1RS, 2SR), (1RS, 2RS), (1R, 2S), (1S, 2S), (1R, 2R) or (1S, 2R); and R, R 1 , R 2 , R 3 and Ar are as defined in the specification. The derivative is non-opioid analgesic, has good analgesic effect and relatively small side effects. The invention also relates to a composition comprising the derivative and its use.
    该发明涉及一种由以下通用公式表示的取代苯基哌嗪芳基烷醇衍生物及其盐和水合物,其中C1和C2代表手性碳原子,化合物是六种异构体之一:(1RS, 2SR)、(1RS, 2RS)、(1R, 2S)、(1S, 2S)、(1R, 2R)或(1S, 2R);R、R1、R2、R3和Ar如规范中所定义。该衍生物是一种非阿片类镇痛药,具有良好的镇痛效果和相对较小的副作用。该发明还涉及包含该衍生物及其用途的组合物。
  • Heat-stable D-aminoacylase
    申请人:——
    公开号:US20020090713A1
    公开(公告)日:2002-07-11
    The present invention provides a novel D-aminoacylase, as well as method for producing a D-amino acid using the same. In order to achieve the above objective, the present inventors have succeeded in purifying heat-stable D-aminoacylase from microorganisms belonging to the genus Streptomyces by combining various purification methods. Furthermore, the present inventors found that the purified heat-stable D-aminoacylase is useful in industrial production of D-amino acids. By utilizing the heat-stable D-aminoacylase, it is possible to readily and efficiently produce the corresponding D-amino acids from N-acetyl-DL-amino acids (for example, N-acetyl-DL-methionine, N-acetyl-DL-valine, N-acetyl-DL-tryptophan, N-acetyl-DL-phenylalanine, N-acetyl-DL-alanine, N-acetyl-DL-leucine, and so on).
    本发明提供了一种新型的D-氨基酰基酶,以及利用该酶生产D-氨基酸的方法。为了实现上述目标,本发明者通过结合各种纯化方法成功地从属于链霉菌属微生物中纯化出耐热的D-氨基酰基酶。此外,本发明者发现,纯化的耐热D-氨基酰基酶在工业生产D-氨基酸中非常有用。通过利用耐热的D-氨基酰基酶,可以方便且高效地从N-乙酰-DL-氨基酸(例如N-乙酰-DL-蛋氨酸、N-乙酰-DL-缬氨酸、N-乙酰-DL-色氨酸、N-乙酰-DL-苯丙氨酸、N-乙酰-DL-丙氨酸、N-乙酰-DL-亮氨酸等)中轻松高效地生产相应的D-氨基酸。
  • D-aminoacylase mutants
    申请人:Daicel Chemical Industries, Ltd.
    公开号:US20040197880A1
    公开(公告)日:2004-10-07
    The present invention provides mutant D-aminoacylases and use thereof. The mutant D-aminoacylases are hard to be inhibited by the substrate and, comprise the amino acid sequences of the D-aminoacylase derived from Alcaligenes denitrificans subsp. xylosoxydans MI-4 strain, wherein amino acid residues at specific sites have been modified. The mutants of the present invention have high reaction specificity as well as resistance to inhibition by the substrate. The present invention enables high-yield production of D-amino acids using higher concentrations of N-acyl-DL-amino acid as the substrate. The mutants of the present invention are useful in producing D-tryptophan in particular.
    本发明提供了突变的D-氨酰酶及其应用。这些突变的D-氨酰酶不容易被底物抑制,并且包括源自Alcaligenes denitrificans subsp. xylosoxydans MI-4菌株的D-氨酰酶的氨基酸序列,其中特定位点的氨基酸残基已经被修改。本发明的突变体具有高反应特异性以及对底物抑制的抵抗能力。本发明实现了利用更高浓度的N-酰-DL-氨基酸作为底物高产D-氨基酸。本发明的突变体在特别用于生产D-色氨酸方面具有用途。
  • 2-(2-HYDROXYBIPHENYL-3-YL)-1H-BENZOIMIDAZOLE-5-CARBOXAMIDINE DERIVATIVES AS FACTOR VIIA INHIBITORS
    申请人:Kolesnikov Aleksandr
    公开号:US20110269806A1
    公开(公告)日:2011-11-03
    The present invention relates to novel inhibitors of Factors VIIa, IXa, Xa, XIa, in particular Factor VIIa, pharmaceutical compositions comprising these inhibitors, and methods for using these inhibitors for treating or preventing thromboembolic disorders, cancer or rheumatoid arthritis. Processes for preparing these inhibitors are also disclosed.
    本发明涉及新型因子VIIa、IXa、Xa、XIa抑制剂,特别是因子VIIa,以及包含这些抑制剂的制药组合物,以及使用这些抑制剂治疗或预防血栓栓塞性疾病、癌症或类风湿性关节炎的方法。本发明还公开了制备这些抑制剂的过程。
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物